1[1]Baguet JP,Robutail S,Boyer L,et al.Meta-analysis approach to the efficacy of antihypertensive drugs in reducing blood pressure[J].J Cardiovase Drugs,2005,5(2):1-10.
3[3]Black HR,Cohen JD,Kaplan NM,et al.The six report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure[J].Arch Intern Med,1997,157(21):2413-2446.
4[4]Inglfiager JR.Ambulatory blood pressure monitoring as a predictive tool[J].New Engl J Med,2002,347:778-779.
5[5]Williams B,Lacy PS,Thorn SM,et al.Differential impact of Mood pressure-lowering drug on central aortic pressure and clinical outcomes:principal result of the conduit artery function evaluation(CAF?)study[J].Circulation,2006,113:1213-1225.
6[6]Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the jiont national committee on prevention,detection,evaluation,and treatment of high blood pressure[J].JAMA,2003,289:2560-2571.
7[7]Bruncnberg DE,Wetzels GE,Nelemans PJ,et al.Cost effectiveness of an adherence-improving programme in hypertensive patients[J].Pharmacoecnomics,2007,25(3):239-251.
8[8]Meredith PA.Trough:peak ratio and smoothness index for antihypertensive agents[J].Blood Press Monit,1999,4(5):257-262.
9[9]Neutel JM.The importance of 24-h blood pressure control[J].Blood Pressure Monitoring,2001,6(1):9-16.
10[10]Kronsel-Weed M,Thomas S,Muntner P,et al.Medication adherence:a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients[J].Curr Opin Cardiol,2004,19(4):357-362.
